Fresenius Wants GranuFlo MDL in Mass., As Plaintiffs Push for Alternative Venues

WASHINGTON, D.C. — Fresenius USA has filed documents with the Judicial Panel on Multidistrict Litigation, supporting a petition to create an MDL docket in Massachusetts for claims alleging injury and death caused by the company’s GranuFlo and Naturalyte dialysis products.

In a response brief filed Jan. 3, Fresenius says that while it agrees with plaintiffs that Massachusetts is the best venue for the coordinated pretrial discovery, claims against the Waltham, Mass.-based manufacturer will ultimately fail because there exists no evidence that the dialysates are dangerous or caused the plaintiffs’ alleged injuries.

Meanwhile, counsel for plaintiffs who filed what is believed …